Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

The awardees for the second round of the University of Oxford’s Enriching Engagement funding scheme have now been announced, including a project from Paediatrics.

Star-shaped trophy

Enriching Engagement is a Wellcome-funded grants programme open to Wellcome grant holders and awardees at the University of Oxford, to develop and deliver Public Engagement with Research projects. 

Round 2 awardees are:

  1. Dr Catherine Manning (Department of Experimental Psychology) -  "Sensory Street”
  2. Dr Jacinta O’Shea (Department of Psychiatry) - "Building stress resilience in early adolescence”
  3. Professor Anne Goriely (Weatherall Institute of Molecular Medicine, Radcliffe Department of Medicine) - “Me and my genome: What am I really made of?”
  4. Dr Carlo Rinaldi (Department of Paediatrics) - "Muscle Switch"
  5. Professor Jane Mckeating (Nuffield Department of Medicine) - "Understanding viruses: combining science and art to empower young people”
  6. Dr Anna Mitchell (Department of Experimental Psychology) - "APE: Animations and Public Engagement to promote transparency in primate neuroscience research”

Full details of each project are available on the University of Oxford website

Similar stories

AR cooperates with SMAD4 to maintain skeletal muscle homeostasis

Skeletal muscle, which accounts for over 40% of the total mass in healthy individuals, plays a central role in maintenance of organismal homeostasis. Conversely, muscle atrophy upon acute and chronic conditions, ranging from genetic muscular dystrophy to critical illnesses, cachexia and sarcopenia, significantly correlates with levels of disability and is an important predictor of mortality. Despite the urgent medical need, treatments able to efficiently counteract muscle loss are lacking due to an incomplete understanding of the underlying intricate molecular mechanisms of regulation.

Oxford scientist named Australian of the Year in the UK

The Oxford Vaccine Group’s Lead Statistician, Professor Merryn Voysey, received the prestigious Australian of the Year in the UK award at a gala dinner recently.

Angelman syndrome: first patient to receive potential therapy in Oxford

Things that seemed impossible, only a few years ago, are happening today. The first patient in Europe and one of the first in the world was injected with a potential treatment, GTX-102, in a phase I/II clinical trial in Oxford.

Promising discovery for treatment of neuromuscular diseases

Research led by Carlo Rinaldi and Catheryn Lim discovered that a naturally-occurring isoform of an androgen receptor can be used in therapy for spinal and bulbar muscular atrophy, and shows potential for other diseases.

University of Oxford researchers among recipients of Ireland and UK joint research awards for digital humanities in €6.5m boost for interdisciplinary research partnerships

Dr Samantha Vanderslott (Oxford Vaccine Group) and Dr Claas Kirchhelle (University College Dublin) have had their three-year project ‘Typhoid, Cockles, and Terrorism’ about the history of typhoid in Dublin successfully funded.

Oxford Vaccine Group among winners at NHS Parliamentary awards

Researchers behind the Oxford AstraZeneca coronavirus vaccine have been recognised for their excellence at a healthcare awards ceremony.